释放工程免疫细胞治疗实体瘤的潜力

IF 15.7 1区综合性期刊 Q1 MULTIDISCIPLINARY SCIENCES

Nature Communications Pub Date : 2025-01-29 DOI:10.1038/s41467-025-56527-0

Víctor Albarrán-Fernández, Laura Angelats, Julio Delgado, Alena Gros, Álvaro Urbano-Ispizua, Sònia Guedan, Aleix Prat

引用次数: 0

摘要

过继细胞疗法已成为治疗晚期实体恶性肿瘤的一种很有前途的方法。基因工程技术代表了一个令人兴奋的研究领域，用于开发具有增强细胞毒性，表型和代谢的细胞产物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Unlocking the potential of engineered immune cell therapy for solid tumors

查看原文本刊更多论文

Unlocking the potential of engineered immune cell therapy for solid tumors

Adoptive cell therapy has emerged as a promising approach for treating advanced solid malignancies. Genetic engineering techniques represent an exciting area of research for the development of cellular products with enhanced cytotoxicity, phenotype, and metabolism.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature Communications Biological Science Disciplines-

CiteScore

24.90

自引率

2.40%

发文量

6928

审稿时长

3.7 months

期刊介绍： Nature Communications, an open-access journal, publishes high-quality research spanning all areas of the natural sciences. Papers featured in the journal showcase significant advances relevant to specialists in each respective field. With a 2-year impact factor of 16.6 (2022) and a median time of 8 days from submission to the first editorial decision, Nature Communications is committed to rapid dissemination of research findings. As a multidisciplinary journal, it welcomes contributions from biological, health, physical, chemical, Earth, social, mathematical, applied, and engineering sciences, aiming to highlight important breakthroughs within each domain.